Characteristics of episodes among those with type 2 diabetes by treatment modality
| Insulin with or without OHA | OHA alone | Not known | p Value | |
|---|---|---|---|---|
| Episodes | 458 (69%) | 195 (29%) | 11 (2%) | <0.001 |
| Pretreatment CBG (mmol/L) | 1.91 (±0.70) | 2.06 (±0.64) | 0.0113 | |
| Post-treatment CBG (mmol/L) | 6.22 (±2.63) | 6.00 (±2.56) | 0.3220 | |
| OHA use | 48 (10.5%) | |||
| Sulfonylurea (alone and in combo) | 14 (3%) | 159 (82%) | ||
| Metformin alone | 26 (6%) | 5 (2.5%) | ||
| Pioglitazone alone | 0 | 1 (0.5%) | ||
| Unknown | 5 (1%) | 30 (15%) | ||
| Other | 3 (0.5%) | 0 | ||
| Mean HbA1c (mmol/mol) | 67.0 (±17.0) | 53.0 (±18.0) | <0.0001 |
CBG, capillary blood glucose, HbA1c, glycated hemoglobin; OHA, oral hypoglycemic agent.